메뉴 건너뛰기




Volumn 160, Issue 6, 2003, Pages 1117-1124

Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINO ACID; BRANCHED CHAIN AMINO ACID; NEUROLEPTIC AGENT; PLACEBO;

EID: 0038149630     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.6.1117     Document Type: Article
Times cited : (64)

References (40)
  • 1
  • 5
    • 33444456937 scopus 로고    scopus 로고
    • Treatment of Tardive Dyskinesia With Leucine, Isoleucine, Valine, or Mixtures Thereof (patent number 5,393,784). Washington, DC, US Patent and Trademark Office, 1995
    • Richardson MA: Treatment of Tardive Dyskinesia With Leucine, Isoleucine, Valine, or Mixtures Thereof (patent number 5,393,784). Washington, DC, US Patent and Trademark Office, 1995
    • Richardson, M.A.1
  • 8
    • 0026439134 scopus 로고
    • Effect of branched-chain amino acid supplementation on the exercise-induced change in aromatic amino acid concentration in human muscle
    • Blomstrand E, Newsholme EA: Effect of branched-chain amino acid supplementation on the exercise-induced change in aromatic amino acid concentration in human muscle. Acta Physiol Scand 1992; 146:293-298
    • (1992) Acta Physiol Scand , vol.146 , pp. 293-298
    • Blomstrand, E.1    Newsholme, E.A.2
  • 9
    • 33444458696 scopus 로고
    • Alterations in protein kinetics produced by branched chain amino acid administration during infection and inflammation
    • Edited by Walser M, Williamson JR. New York, Elsevier-North Holland
    • Moldawer LL, Sakamoto A, Blackburn GL, Bistrian BR: Alterations in protein kinetics produced by branched chain amino acid administration during infection and inflammation, in Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids. Edited by Walser M, Williamson JR. New York, Elsevier-North Holland, 1981, pp 533-539
    • (1981) Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids , pp. 533-539
    • Moldawer, L.L.1    Sakamoto, A.2    Blackburn, G.L.3    Bistrian, B.R.4
  • 10
    • 0001688801 scopus 로고
    • Branched-chain amino and keto acids as regulators of insulin and glucagon release
    • Edited by Adibi SA, Fekl W, Langenbeck U, Schauder P. Basel, Karger
    • Malaisse WJ: Branched-chain amino and keto acids as regulators of insulin and glucagon release, in Branched-Chain Amino and Keto Acids in Health and Disease. Edited by Adibi SA, Fekl W, Langenbeck U, Schauder P. Basel, Karger, 1984, pp 119-133
    • (1984) Branched-Chain Amino and Keto Acids in Health and Disease , pp. 119-133
    • Malaisse, W.J.1
  • 11
    • 0025201970 scopus 로고
    • Effect of infused branched-chain amino acids on muscle and whole-body amino acid metabolism in man
    • Louard RJ, Barrett EJ, Gelfand RA: Effect of infused branched-chain amino acids on muscle and whole-body amino acid metabolism in man. Clin Sci 1990; 79:457-466
    • (1990) Clin Sci , vol.79 , pp. 457-466
    • Louard, R.J.1    Barrett, E.J.2    Gelfand, R.A.3
  • 12
    • 0013509257 scopus 로고
    • Plasma branched-chain amino acids as regulators of brain neurotransmitters
    • Edited by Adibi SA, Fekl W, Langenbeck U, Schauder P. Basel, Karger
    • Maher TJ: Plasma branched-chain amino acids as regulators of brain neurotransmitters, in Branched-Chain Amino and Keto Acids in Health and Disease. Edited by Adibi SA, Fekl W, Langenbeck U, Schauder P. Basel, Karger, 1984, pp 242-259
    • (1984) Branched-Chain Amino and Keto Acids in Health and Disease , pp. 242-259
    • Maher, T.J.1
  • 13
    • 0025150823 scopus 로고
    • Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy: A randomized double-blind casein-controlled trial
    • Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L, Marlines D, Abbiati R: Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy: a randomized double-blind casein-controlled trial. J Hepatol 1990; 11:92-101
    • (1990) J Hepatol , vol.11 , pp. 92-101
    • Marchesini, G.1    Dioguardi, F.S.2    Bianchi, G.P.3    Zoli, M.4    Bellati, G.5    Roffi, L.6    Marlines, D.7    Abbiati, R.8
  • 16
    • 0020084370 scopus 로고
    • The coexistence of parkinsonism-like symptoms and tardive dyskinesia
    • Richardson MA, Craig TJ: The coexistence of parkinsonism-like symptoms and tardive dyskinesia. Am J Psychiatry 1982; 139:341-343
    • (1982) Am J Psychiatry , vol.139 , pp. 341-343
    • Richardson, M.A.1    Craig, T.J.2
  • 18
    • 0020050047 scopus 로고
    • Intra-patient variability in the measurement of tardive dyskinesia
    • Berl
    • Richardson MA, Craig TJ, Branchey MH: Intra-patient variability in the measurement of tardive dyskinesia. Psychopharmacology (Berl) 1982; 76:269-272
    • (1982) Psychopharmacology , vol.76 , pp. 269-272
    • Richardson, M.A.1    Craig, T.J.2    Branchey, M.H.3
  • 19
    • 9344245871 scopus 로고
    • Methodological approach to the measurement of tardive dyskinesia: Piezoelectric recording and concurrent validity test of five clinical rating scales
    • Edited by Fann WE, Smith RC, Davis JM, Domino EF. New York, SP Medical and Scientific Books
    • Chien C, Jung K, Ross-Townsend A: Methodological approach to the measurement of tardive dyskinesia: piezoelectric recording and concurrent validity test of five clinical rating scales, in Tardive Dyskinesia Research and Treatment. Edited by Fann WE, Smith RC, Davis JM, Domino EF. New York, SP Medical and Scientific Books, 1980, pp 233-241
    • (1980) Tardive Dyskinesia Research and Treatment , pp. 233-241
    • Chien, C.1    Jung, K.2    Ross-Townsend, A.3
  • 20
    • 0017655083 scopus 로고
    • Oral choline administration to patients with tardive dyskinesia
    • Growdon JH, Hirsch MJ, Wurtman RJ, Wiener W: Oral choline administration to patients with tardive dyskinesia. N Engl J Med 1977; 297:524-527
    • (1977) N Engl J Med , vol.297 , pp. 524-527
    • Growdon, J.H.1    Hirsch, M.J.2    Wurtman, R.J.3    Wiener, W.4
  • 22
    • 0015364024 scopus 로고
    • Treatment of tardive dyskinesia, I: Clinical efficacy of a dopamine-depleting agent, tetrabenazine
    • Kazamatsuri H, Chien C, Cole JO: Treatment of tardive dyskinesia, I: clinical efficacy of a dopamine-depleting agent, tetrabenazine. Arch Gen Psychiatry 1972; 27:95-99
    • (1972) Arch Gen Psychiatry , vol.27 , pp. 95-99
    • Kazamatsuri, H.1    Chien, C.2    Cole, J.O.3
  • 24
    • 0024246342 scopus 로고
    • Tardive dyskinesia status: Stability or change
    • Richardson MA, Casey DE: Tardive dyskinesia status: stability or change. Psychopharmacol Bull 1988; 24:471-475
    • (1988) Psychopharmacol Bull , vol.24 , pp. 471-475
    • Richardson, M.A.1    Casey, D.E.2
  • 26
    • 0033973363 scopus 로고    scopus 로고
    • Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia
    • Sirota P, Mosheva T, Shabtay H, Giladi N, Korczyn AD: Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia. Am J Psychiatry 2000; 157:287-289
    • (2000) Am J Psychiatry , vol.157 , pp. 287-289
    • Sirota, P.1    Mosheva, T.2    Shabtay, H.3    Giladi, N.4    Korczyn, A.D.5
  • 27
    • 0003658949 scopus 로고    scopus 로고
    • Cary, NC, SAS Institute
    • SAS Version 8.1. Cary, NC, SAS Institute, 1999
    • (1999) SAS Version 8.1
  • 28
    • 0017654351 scopus 로고
    • Pharmacological characterization of tardive dyskinesia
    • Berl
    • Casey DE, Denney D: Pharmacological characterization of tardive dyskinesia. Psychopharmacology (Berl) 1977; 54:1-8
    • (1977) Psychopharmacology , vol.54 , pp. 1-8
    • Casey, D.E.1    Denney, D.2
  • 30
  • 31
    • 0026666282 scopus 로고
    • Gender differences in tardive dyskinesia: A critical review of the literature
    • Yassa R, Jeste DV: Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 1992; 18:701-715
    • (1992) Schizophr Bull , vol.18 , pp. 701-715
    • Yassa, R.1    Jeste, D.V.2
  • 32
    • 0021207203 scopus 로고
    • Factors contributing to the prevalence and severity of tardive dyskinesia
    • Richardson MA, Pass R, Craig TJ, Vickers E: Factors contributing to the prevalence and severity of tardive dyskinesia. Psychopharmacol Bull 1984; 20:33-38
    • (1984) Psychopharmacol Bull , vol.20 , pp. 33-38
    • Richardson, M.A.1    Pass, R.2    Craig, T.J.3    Vickers, E.4
  • 33
    • 0017812025 scopus 로고
    • Tardive dyskinesia: Age and sex differences in hospitalized schizophrenics
    • Berl
    • Smith JM, Oswald WT, Kucharski LT, Waterman LJ: Tardive dyskinesia: age and sex differences in hospitalized schizophrenics. Psychopharmacology (Berl) 1978; 58:207-211
    • (1978) Psychopharmacology , vol.58 , pp. 207-211
    • Smith, J.M.1    Oswald, W.T.2    Kucharski, L.T.3    Waterman, L.J.4
  • 34
    • 0025853254 scopus 로고
    • Plasma amino acid concentrations in healthy elderly men and women
    • Caballero B, Gleason RE, Wurtman RJ: Plasma amino acid concentrations in healthy elderly men and women. Am J Clin Nutr 1991; 53:1249-1252
    • (1991) Am J Clin Nutr , vol.53 , pp. 1249-1252
    • Caballero, B.1    Gleason, R.E.2    Wurtman, R.J.3
  • 35
    • 0022967066 scopus 로고
    • Plasma free amino acid values in normal children and adolescents
    • Gregory DM, Sovetts D, Clow CL, Scriver CR: Plasma free amino acid values in normal children and adolescents. Metabolism 1986; 35:967-969
    • (1986) Metabolism , vol.35 , pp. 967-969
    • Gregory, D.M.1    Sovetts, D.2    Clow, C.L.3    Scriver, C.R.4
  • 36
    • 0024558679 scopus 로고
    • Influence of gender and menopause on gastric emptying and motility
    • Hutson WR, Roehrkasse RL, Wald A: Influence of gender and menopause on gastric emptying and motility. Gastroenterology 1989; 96:11-17
    • (1989) Gastroenterology , vol.96 , pp. 11-17
    • Hutson, W.R.1    Roehrkasse, R.L.2    Wald, A.3
  • 37
    • 33444473969 scopus 로고
    • Branched chain amino acids and inborn errors of metabolism
    • Edited by Kinney JM, Borum PR. Baltimore, Urban & Schwarzenburg
    • Berry HK: Branched chain amino acids and inborn errors of metabolism, in Perspectives in Clinical Nutrition. Edited by Kinney JM, Borum PR. Baltimore, Urban & Schwarzenburg, 1989, pp 207-218
    • (1989) Perspectives in Clinical Nutrition , pp. 207-218
    • Berry, H.K.1
  • 38
    • 0019959175 scopus 로고
    • Reduction of cerebrospinal fluid phenylalanine after oral administration of valine, isoleucine and leucine
    • Berry HK, Bofinger MK, Hunt MM, Phillips PJ, Guilfaile MB: Reduction of cerebrospinal fluid phenylalanine after oral administration of valine, isoleucine and leucine. Pediatr Res 1982; 16:751-755
    • (1982) Pediatr Res , vol.16 , pp. 751-755
    • Berry, H.K.1    Bofinger, M.K.2    Hunt, M.M.3    Phillips, P.J.4    Guilfaile, M.B.5
  • 39
    • 0033560647 scopus 로고    scopus 로고
    • Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria
    • Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, Bremer HJ: Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest 1999; 103:1169-1178
    • (1999) J Clin Invest , vol.103 , pp. 1169-1178
    • Pietz, J.1    Kreis, R.2    Rupp, A.3    Mayatepek, E.4    Rating, D.5    Boesch, C.6    Bremer, H.J.7
  • 40
    • 0344765524 scopus 로고    scopus 로고
    • Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria
    • Moller HE, Weglage J, Wiedermann D, Ullrich K: Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria. J Cereb Blood Flow Metab 1998; 18:1184-1191
    • (1998) J Cereb Blood Flow Metab , vol.18 , pp. 1184-1191
    • Moller, H.E.1    Weglage, J.2    Wiedermann, D.3    Ullrich, K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.